
Ambulatory Cardiac Monitoring Devices Market Report and Forecast 2025-2034
Description
The global ambulatory cardiac monitoring devices market size was valued at USD 9.79 Billion in 2024, driven by the rising number of global research and development activities. The market size is anticipated to grow at a CAGR of 8.80% during the forecast period of 2025-2034 to achieve a value of USD 22.75 Billion by 2034.
Ambulatory Cardiac Monitoring Devices: Introduction
Ambulatory electrical monitors are used to record the electrical activity in the heart over a long period. These devices are wearable and convenient, allowing the patient to wear them easily. They can be worn for days, weeks, or even years. They can be used to diagnose problems that may happen unpredictably even if the patient is not under the supervision of a healthcare professional.
Ambulatory monitors can diagnose arrhythmias, which are irregular heart rhythms. Some common types of arrhythmias include bradyarrhythmias, tachyarrhythmias, supraventricular arrhythmias, and ventricular arrhythmias.
Global Ambulatory Cardiac Monitoring Devices Market Analysis
The growth of the global market for ambulatory cardiac monitoring devices is majorly driven by the rising geriatric population, which is both an opportunity and a challenge. The rising cardiovascular disorders across the globe are also driving the market growth. The rise in cardiovascular disorder cases and the increasing geriatric population are majorly contributing to the increasing demand for ambulatory cardiac monitoring devices in the market.
The increasing technological advancements are also gaining traction from healthcare professionals and facilities that are interested in providing the best services to the patient when it comes to cardiac care. Such developments are rapidly aiding the global ambulatory cardiac monitoring devices market growth. The integration of advanced technologies, such as artificial intelligence and machine learning in the healthcare sector, such as ambulatory monitoring devices, greatly influence the market growth as this integration brings clinical confidence and increases efficiency.
The increasing technological development in the market resulting from the increased number of clinical studies to improve the functionality of existing monitoring devices or developing new ones from scratch is a major trend intensifying the market growth. For example, the use of Philips MCOT (Mobile Cardiac Outpatient Telemetry) solutions, based on prescriptions, may result in less expenditure and better patient outcomes by monitoring for arrhythmic disturbances and promoting timely interventions, propelling the market growth. The introduction of smart devices with the integration of advanced technologies, such as machine learning and artificial intelligence, are also driving the growth of the global ambulatory cardiac monitoring devices market.
The increasing number of clinical trials to develop new devices and technologies for better results are also expected to drive the market growth in the coming years.
Global Ambulatory Cardiac Monitoring Devices Market Segmentations
Ambulatory Cardiac Monitoring Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
The growth of the global market is driven by the increasing geriatric population as older people are more susceptible to health conditions, such as high blood pressure, heart failure, diabetes, and thyroid disease, that may lead to arrhythmias. Arrhythmias caused by congenital heart defects or inherited conditions are common in children and young adults.
Key players in the market and governments are greatly investing in research and development activities associated with the development of newly advanced ambulatory cardiac monitoring devices to improve results and patient experiences, which is further driving the global ambulatory cardiac monitoring devices market growth. The presence of robust reimbursement and regulatory policies in developed and emerging economies is expected to directly contribute to the growth of the market during the forecast period. Studies say that nearly 80% of premature heart attacks and strokes are preventable if diagnosed timely. The increasing number of research and clinical studies to overcome the increasing prevalence of cardiovascular diseases and disorders are driving the market growth.
Global Ambulatory Cardiac Monitoring Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Ambulatory Cardiac Monitoring Devices: Introduction
Ambulatory electrical monitors are used to record the electrical activity in the heart over a long period. These devices are wearable and convenient, allowing the patient to wear them easily. They can be worn for days, weeks, or even years. They can be used to diagnose problems that may happen unpredictably even if the patient is not under the supervision of a healthcare professional.
Ambulatory monitors can diagnose arrhythmias, which are irregular heart rhythms. Some common types of arrhythmias include bradyarrhythmias, tachyarrhythmias, supraventricular arrhythmias, and ventricular arrhythmias.
Global Ambulatory Cardiac Monitoring Devices Market Analysis
The growth of the global market for ambulatory cardiac monitoring devices is majorly driven by the rising geriatric population, which is both an opportunity and a challenge. The rising cardiovascular disorders across the globe are also driving the market growth. The rise in cardiovascular disorder cases and the increasing geriatric population are majorly contributing to the increasing demand for ambulatory cardiac monitoring devices in the market.
The increasing technological advancements are also gaining traction from healthcare professionals and facilities that are interested in providing the best services to the patient when it comes to cardiac care. Such developments are rapidly aiding the global ambulatory cardiac monitoring devices market growth. The integration of advanced technologies, such as artificial intelligence and machine learning in the healthcare sector, such as ambulatory monitoring devices, greatly influence the market growth as this integration brings clinical confidence and increases efficiency.
The increasing technological development in the market resulting from the increased number of clinical studies to improve the functionality of existing monitoring devices or developing new ones from scratch is a major trend intensifying the market growth. For example, the use of Philips MCOT (Mobile Cardiac Outpatient Telemetry) solutions, based on prescriptions, may result in less expenditure and better patient outcomes by monitoring for arrhythmic disturbances and promoting timely interventions, propelling the market growth. The introduction of smart devices with the integration of advanced technologies, such as machine learning and artificial intelligence, are also driving the growth of the global ambulatory cardiac monitoring devices market.
The increasing number of clinical trials to develop new devices and technologies for better results are also expected to drive the market growth in the coming years.
Global Ambulatory Cardiac Monitoring Devices Market Segmentations
Ambulatory Cardiac Monitoring Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- ECG Devices
- Holter Monitors
- Event Monitors
- Implantable Loop Recorders
- Mobile Cardiac Telemetry
- Hospitals and Clinics
- Ambulatory Care Centers
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The growth of the global market is driven by the increasing geriatric population as older people are more susceptible to health conditions, such as high blood pressure, heart failure, diabetes, and thyroid disease, that may lead to arrhythmias. Arrhythmias caused by congenital heart defects or inherited conditions are common in children and young adults.
Key players in the market and governments are greatly investing in research and development activities associated with the development of newly advanced ambulatory cardiac monitoring devices to improve results and patient experiences, which is further driving the global ambulatory cardiac monitoring devices market growth. The presence of robust reimbursement and regulatory policies in developed and emerging economies is expected to directly contribute to the growth of the market during the forecast period. Studies say that nearly 80% of premature heart attacks and strokes are preventable if diagnosed timely. The increasing number of research and clinical studies to overcome the increasing prevalence of cardiovascular diseases and disorders are driving the market growth.
Global Ambulatory Cardiac Monitoring Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott
- Boston Scientific Corporation
- GE Healthcare
- Cardinal Health
- Hill-Rom Holdings
- Koninklijke Philips N.V.
- Medtronic
- Nihon Kohden
- CorporationAsahi Kasei Corporation
- BIOTRONIK SE & Co KG
- BPL Medical Technologies
- iRhythm Technologies, Inc.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Ambulatory Cardiac Monitoring Devices Market Overview
- 3.1 Global Ambulatory Cardiac Monitoring Devices Market Historical Value (2018-2024)
- 3.2 Global Ambulatory Cardiac Monitoring Devices Market Forecast Value (2025-2034)
- 4 Global Ambulatory Cardiac Monitoring Devices Market Landscape
- 4.1 Global Ambulatory Cardiac Monitoring Devices Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Ambulatory Cardiac Monitoring Devices Product Landscape
- 4.2.1 Analysis by Type
- 5 Global Ambulatory Cardiac Monitoring Devices Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Ambulatory Cardiac Monitoring Devices Market Segmentation
- 6.1 Global Ambulatory Cardiac Monitoring Devices Market by Type
- 6.1.1 Market Overview
- 6.1.2 ECG Devices
- 6.1.2.1 Resting ECG Devices
- 6.1.2.2 Stress ECG Devices
- 6.1.3 Holter Monitors
- 6.1.4 Event Monitors
- 6.1.5 Implantable Loop Recorders
- 6.1.6 Mobile Cardiac Telemetry
- 6.2 Global Ambulatory Cardiac Monitoring Devices Market by End User
- 6.2.1 Market Overview
- 6.2.2 Hospitals and Clinics
- 6.2.3 Ambulatory Care Centers
- 6.2.4 Others
- 6.3 Global Ambulatory Cardiac Monitoring Devices Market by Region
- 6.3.1 Market Overview
- 6.3.2 North America
- 6.3.3 Europe
- 6.3.4 Asia Pacific
- 6.3.5 Latin America
- 6.3.6 Middle East and Africa
- 7 North America Ambulatory Cardiac Monitoring Devices Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Ambulatory Cardiac Monitoring Devices Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Ambulatory Cardiac Monitoring Devices Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Ambulatory Cardiac Monitoring Devices Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Ambulatory Cardiac Monitoring Devices Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Abbott
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Boston Scientific Corporation
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 GE Healthcare
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Cardinal Health
- 17.4.1 Financial Analysis
- 17.4.2 Financial Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Hill-Rom Holdings
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Koninklijke Philips N.V.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Medtronic
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Nihon Kohden Corporation
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Asahi Kasei Corporation
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 BIOTRONIK SE & Co KG
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 BPL Medical Technologies
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 iRhythm Technologies, Inc.
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 18 Global Ambulatory Cardiac Monitoring Devices Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.